A quality improvement intervention can reduce inefficiencies in the cardiac catheterization lab.
Preoperatively diagnosed patent foramen ovale is associated with increased risk for perioperative ischemic stroke in adults undergoing noncardiac surgery.
Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.
Compliance with guideline-directed medical therapy is low, but remains higher in PCI than in CABG.
The presence of depressive symptoms among older adults undergoing TAVR or SAVR increases the risk of mortality.
Distance from cardiac catheterization center independently predicts survival in ACS with cardiogenic shock.
A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.
Catheter ablation was associated with a significant reduction in a composite end point of death from any cause or hospitalization for worsening heart failure in patients with atrial fibrillation.
Percutaneous coronary intervention is associated with increased rates of adverse outcomes compared with CABG in patients with 3-vessel CAD.
Clinical practice guidelines for anticoagulation therapy for cardiopulmonary bypass have been developed.
Percutaneous patent foramen ovale closure is superior to medical treatment alone in preventing recurrent strokeJanuary 23, 2018
Patent foramen ovale (PFO) closure was superior to medical treatment alone in preventing transient ischemic attack and recurrent stroke. However, PFO closure also raised the risk for atrial fibrillation or atrial flutter in people with PFO and cryptogenic stroke.
Thrombectomy performed between 6 and 24 hours after onset of acute stroke in patients with a mismatch between stroke symptoms and infarct volume results in better disability outcomes compared to standard care alone.
The risk of mortality is increased for certain patients undergoing percutaneous coronary intervention with incomplete revascularization.
For patients with severe aortic stenosis, left ventricular ejection fraction <60% is associated with impaired survival.
Thrombocytopenia at hospital admission may be an independent predictor for in-hospital mortality in patients with rheumatic heart disease undergoing valve replacement surgery.
Preoperative accelerometry can assess cardiopulmonary fitness in patients scheduled for major surgery.
Uninterrupted and minimally interrupted apixaban are associated with low rates of thromboembolic events in patients undergoing catheter ablation for nonvalvular afib.
Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.
Endovascular strategy is associated with better survival rate and decreased hospital costs compared to open repair in ruptured abdominal aortic aneurysm.
About 17.6% of patients with peripheral arterial disease are readmitted.
Despite safety concerns for patients 70 and older, the odds of carotid artery stenting have increased.
Perioperative aspirin seems to be beneficial for patients with prior PCI.
Intravenous sodium bicarbonate is not superior to intravenous sodium chloride for reducing acute kidney injury during angiography.
A restrictive threshold for red-cell transfusion is noninferior to a liberal threshold for patients undergoing cardiac surgery.
No evidence shows efficacy of PCI procedures for patients with stable coronary artery disease with angina.
Percutaneous coronary intervention does not increase exercise time more than a placebo procedure in patients with angina and severe coronary stenosis.
Alternative antiplatelet therapy after percutaneous coronary intervention in patients with a CYP2C19 loss-of-function allele may have lower risk of MACE compared to clopidogrel.
Percutaneous coronary intervention of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI in patients with patients with multivessel CAD and acute MI.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
The Cardiology Advisor Articles
- A 45-Year-Old Man Presents to the ED With Shortness of Breath, Confusion
- A 56-Year-Old Man With Flu-Like Symptoms Presents With Palpitations
- Acute Coronary Syndrome Benefits From Both Antiplatelets and DOACs
- 6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH
- Fear of E-Cigarette Harm Cuts Teenagers' Use
- Clopidogrel Tablets Recalled Due to Mislabeling
- Mandatory Screening for Congenital Heart Disease: Effects on Infant Mortality
- Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk
- Effects of High-Intensity Exercise Training in Previously Sedentary Adults
- ACC Releases Decision Pathway on Heart Failure With Reduced Ejection Fraction
- Clinical Challenge: Upper Respiratory Infection 1 Year After Heart Transplant
- Use of Multiple Antihypertensive Agents Has Increased in Hospitalizations Complicated by Preeclampsia
- Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation
- Metformin May Preserve Beta-Cell Function in T2DM
- A 67-Year-Old Man With Shortness of Breath After the Sonoma-Napa Wildfires